Clinical experience of capecitabine in metastatic breast cancer
- 1 February 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, 10-14
- https://doi.org/10.1016/s0959-8049(01)00416-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patientsCancer, 2001
- Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancerAnnals of Oncology, 2001
- Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal CancerJNCI Journal of the National Cancer Institute, 1996
- A study of quality of life in cancer patients receiving palliative chemotherapySocial Science & Medicine, 1992